TY -的T1低传输< em >伪的风险monas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02191-2018 VL - 53 IS - 3 SP - 1802191 AU - Cramer, Nina AU - Sedlacek, Ludwig AU - Tümmler, Burkhard AU - Welte, Tobias Y1 - 2019/03/01 UR - //www.qdcxjkg.com/content/53/3/1802191.abstract N2 - The nosocomial acquisition of opportunistic pathogens, particularly Pseudomonas aeruginosa, has been repeatedly documented in individuals with cystic fibrosis (CF) [1]. Cross-infection is also a concern in bronchiectasis not due to CF [2]. This issue was not addressed by the European Respiratory Society 2017 guidelines for the management of adult bronchiectasis [3] but the European Bronchiectasis Network (EMBARC), the EMBARC Patient Advisory Group and the European Reference Network (ERN-Lung) Bronchiectasis Network released a position statement in the European Respiratory Journal in 2018 [4]. Based on the available evidence, the risk of cross-infection with P. aeruginosa was judged to be small.This study suggests that the risk of cross-infection with P. aeruginosa in bronchiectasis is small http://ow.ly/itUa30nrgET ER -